Science Abstracts
Management of the side effects of androgen deprivation therapy in men with prostate cancer
May 2012
May 2012
Authors : Thomas W Flaig , L Michael Glodé
Affliation : University of Colorado Denver School of Medicine, Division of Medical Oncology, Department of Medicine, Mail Stop 8117, PO Box 6511, Aurora, CO 80045 Colorado, USA ; ; Thomas.Flaig@UCHSC.edu
DOI : 10.1517/14656566.0.0.346688
Published in : Expert Opin. Pharmacother.
Subject:
Keywords: adverse events , androgen deprivation therapy , gonadotropin-releasing hormone agonist , prostate cancer
Abstract
Please Login to read the full article.
RELATED CONTENT
NEWS
- Roche expands hepatitis C deal with Merck after Victrelis' EU nod
- Pharmacyclics raises $57M to advance tyrosine kinase inhibitor for blood cancers
- Gilead's Truvada cut risk of HIV infection by up to 78% in heterosexuals
- Familial cholesterol tests from Gen-Probe, Progenika fall short of NICE expectations
FEATURES
Other Informa Features
